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Abstract. The nuclear domain (ND)10 also described 
as POD or Kr bodies is involved in the development of 
acute promyelocytic  leukemia and virus-host interac- 
tions. Immunofluorescence analysis using a variety of 
human autoimmune sera and monoclonal antibodies 
showed a typical dot like nuclear staining for ND10, 
suggesting that this structure consists of several pro- 
teins. Two of the ND10 proteins, Spl00 and PML are 
genetically characterized and show homology with sev- 
eral transcription factors. 
Here we describe NDP52, an additional novel pro- 
tein of the ND10. We raised a new mAb C8A2, that 
specifically recognizes NDP52. Immunofluorescence 
analysis using this mAb showed a typical nuclear dot 
staining as it was described for ND10. Isolation and se- 
quencing of the corresponding cDNA revealed that 
NDP52 has a predicted molecular mass of 52 kD. The 
deduced amino acid sequence exhibits an extended 
central coiled coil domain containing a leucine zipper 
motif. The COOH terminus of NDP52 shows homology 
with LIM domains, that have recently been described 
to mediate protein interactions, which let NDP52 ap- 
pear as a suitable candidate for mediating interactions 
between ND10 proteins. In vivo, NDP52 is transcribed 
in all human tissues analyzed. Furthermore, we show 
that NDP52 colocalizes with the ND10 protein PML 
and can be redistributed upon viral infection and inter- 
feron treatment. These data suggest that ND10 proteins 
play an important role in the viral life cycle. 
T 
HE internal structure and the role of the different 
organelles of the nucleus are less well characterized 
than those of the cytoplasm. Immunohistochemical 
studies and ultrastructural analyses have identified a num- 
ber of nuclear domains, the components and functions of 
which are only partially understood. These structures in- 
clude perichromatin fibrils,  interchromatin granules and 
nuclear bodies (Fakan et al., 1984; Puvion et al., 1984; Visa 
et al.,  1993). Some of the nuclear domains appear in a 
speckled or dot-like distribution within the nucleus.  The 
components of the splicing regions, i.e., SC35 (Fu and Ma- 
niatis,  1990), hnRNPs (Fakan et al.,  1984), and snRNPs 
(Spector et al., 1983), are concentrated in 20-50 nuclear 
speckles. The distribution of these speckles varies among 
different cell types and can be altered by several factors af- 
fecting transcription (Antoniou et al., 1993) and by virus 
infection (Bridge et al., 1993). 
ND10 are nuclear domains, originally characterized using 
mAbs and human autoantisera from patients with primary 
biliary cirrhosis. At the immunohistochemical  level ND10 
appear as nuclear dots, where 10 indicates the approximate 
number of dots observed  per nucleus  (Ascoli  and Maul, 
1991). ND10  did  not  colocalize  with kinetochores,  cen- 
tromeres,  sites  of mRNA processing,  and chromosomes. 
Resistance of ND10 antigens to nuclease digestion and salt 
extraction suggested that ND10 are associated with the nu- 
clear matrix (Ascoli and Maul,  1991). Infection of ND10 
positive cells with herpes simplex virus type-1 (HSV-1)  1 ab- 
rogates immunofluorescent staining of ND10 (Maul et al., 
1993). Using HSV-1 deletion mutants the loss of staining 
was found to be induced by the immediate early gene 1 
product (ICP0) of HSV-1 (Maul et al., 1993; Everett and 
Maul, 1994; Maul and Everett, 1994). 
Immunofluorescence analyses using a variety of human 
autoantisera and antibodies have shown that ND10  are 
composed  of  several  colocalized  proteins.  One  of the 
ND10 antigens, recognized by a mAb 138, was identified 
as a 55-kD protein, occurring as three charge isomers with 
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other ND10 proteins have been characterized by eDNA 
sequence analyses. One of these, Spl00, is an autoantigen 
in primary biliary cirrhosis  (Szostecki et al.,  1990).  The 
transcription and expression of Spl00 were shown to be 
enhanced after virus infection or mitogen and interferon 
(IFN)  treatment  (Guldner  et  al.,  1992).  The  deduced 
amino acid sequence of the human Spl00 revealed some 
homology to  several transcriptional regulatory proteins, 
although the exact biological function of Spl00 is still un- 
known. Recent investigations have shown that ND10 con- 
tain PML (Dyck et al., 1994),  the second ND10 protein 
that has been genetically analyzed. It is involved in acute 
promyelocytic leukemia  (APL),  a  hematopoietic malig- 
nancy in which myeloid precursors are blocked at a prolif- 
erative state. This disease is associated with a specific t (15; 
17) translocation that generates a fusion gene of PML and 
the retinoic acid receptor-or  (de The et al., 1991; Goddard 
et al.,  1991; Kakizuka et al., 1991; Kastner et al.,  1992). 
Compared to the ND10-1ike  distribution of the wild-type 
PML, the resulting fusion protein causes an unusual mi- 
croparticulate pattern of PML and the fusion protein. Ret- 
inoic acid treatment of these APL ceils restores the pat- 
tern of PML to normal appearing ND10 (Dyck et al., 1994; 
Koken et al., 1994; Weis et al., 1994). In vivo the adminis- 
tration of all trans retinoic acid has led to complete remis- 
sion in APL patients (Castaigne et al., 1990). PML shows 
homology with several transcription factors (Kakizuka et 
al., 1991). 
Most ND10 correspond to nuclear bodies (Koken et al., 
1994).  These  large  structures  of  unknown  function re- 
spond to environmental stimuli like interferon and viral 
infection (Maul et al., 1993). Their function in the cell can 
only be elucidated by the identification of further associ- 
ated proteins  and the characterization of their behavior 
under the known modifying conditions. 
In this study we describe a novel protein, NDP52, which 
is recognized by mAb C8A2, and shows the typical ND10 
immunofluorescence staining pattern. NDP52 colocalizes 
with the ND10  proteins  PML and  Spl00.  A  full-length 
eDNA encoding NDP52 was isolated by screening a X-ZAP 
eDNA expression library with mAb C8A2, together with 
extension of the 5' end using the 5'RACE system. NDP52 
is expressed in a variety of cell lines and human tissues, 
and its expression and distribution are modified by differ- 
ent external triggers. 
Materials and Methods 
Antibodies and Cell Culture 
The monoclonal antibody C8A2 was produced by immunizing mice with 
crude nuclei fractions prepared as described by Martelli et aL (1992). Fu- 
sion of spleen cells with the FO Myeloma and cloning of hybridoma were 
performed as described (Fazeka de St. Groth and Scheidegger, 1980). Hy- 
bridoma supernatants were screened for reactive mAbs by indirect immu- 
nofluorescence analysis of permeabilized MG63 cells. PML was visualized 
using a specific rabbit antiserum (Dyck et al., 1994). 
HEp-2 carcinoma cells (CCL 23;  American Type Tissue  Collection, 
Rockville, MD) and the diploid human fibroblast cell line, MRC-5 (CCL 
171) were maintained in MEM. MG63 cells (CRL 1427) were maintained 
in Iscove's DMEM and COS-7 cells (CRL 1651) in DMEM. Further cell 
lines grown for total RNA preparation were Saos-2 (HTB 85) maintained 
in Iscove's DMEM, SK-ES-1 (HTB 86), maintained in McCoy's 5a and 
HeLa  (CCL  2)  maintained in  Eagle's MEM.  All media were supple- 
mented with 10% FCS and cells were grown at 37°C in a humified atmo- 
sphere containing 5% CO2. For immunofluorescence analysis, cells were 
grown on round coverslips in 24-well plates (Coming Glass Inc., Coming, 
NY). For IFN stimulation, 1,000 U/ml of the respective interferon was 
added to the culture medium for 18 h (IFN-13 was kindly provided by Dr. 
Renschler Biotechnology GmbH, Laupheim, Germany; INF-'y was kindly 
provided by the DRK, Springe, Germany). 
Immunofluorescence Microscopy 
HEp-2 and MRC-5 cells were fixed at room temperature for 5 rain with 
freshly prepared 1%  paraformaldehyde in PBS, washed with PBS, and 
permeabilized for 20 min in PBS+0.2% (vol/vol) Triton X-100 (Sigma Im- 
munochemicals, St. Louis, MO) on ice. Nuclear antigen localization was 
determined after incubation of permeabilized cells with rabbit antiserum, 
or mAb diluted in PBS for 1 h at room temperature. For double labeling, 
the weaker of the two primary antibodies was complexed with a secondary 
biotinylated antibody and labeled with avidin-fluorescein or avidin-Texas 
red. The stronger reacting antibody was detected with FITC or Texas red 
labeled secondary antibodies (Vector Labs., Inc., Burlingame, CA). Cells 
were stained for DNA with 0.5 mg/ml of bisBenzimide (Hoechst 33258; 
Sigma) in PBS and mounted with Fluoromount G (Fisher Scientific, Pitts- 
burgh, PA). Fluorescence images were analyzed using a Leica confocal la- 
ser scanning microscope and recorded with a  Focus Imagecorder Plus 
graphics recorder(Leica, Inc., Deerfield, IL). 
Immunofluorescence on MG63  and COS-7 cells were performed at 
room temperature by fixing ceils with 4% (wt/vol) paraformaldehyde in 
PBS for 10 min. Cells were subsequently permeabilized with 0.2%  (vol/ 
vol) Triton X-100 in PBS for 15 min and incubated with 1 mg/ml mAb 
C8A2 in PBS for 1 h. Bound mAb was detected using a goat anti-mouse 
antibody, conjugated with FITC (Sigma, Deisenhofen, Germany). Finally, 
cells were embedded in Moviol 4-88 (Hoechst AG, Frankfurt a. M., Ger- 
many). Specimens were analyzed using a Zeiss Axiophot fluorescence mi- 
croscope equipped for epifluorescence (Carl Zeiss, Inc., Thomwood, NY). 
Immunoprecipitation 
For immunoprecipitation of NDP52 cells were lysed in 10 mM Tris con- 
taining 1% (wt/vol) NP40,150 mM NaC1, pH 7.5 and cemrifuged at 15,000 g 
for 10 min. The supernatant was incubated with mAb C8A2 coupled to 
protein G-Sepharose for 1 h  at 4°C. After extensive washing with lysis 
buffer bound antigen was eluted in SDS sample buffer and analyzed by 
SDS-PAGE. 
Gel Electrophoresis and Immunoblot Analyses 
Proteins  were  separated  by  one-dimensional  SDS-PAGE  (Laemmli, 
1970). For immunoblot analysis proteins were subsequently transferred to 
nitrocellulose filters (Towbin et al., 1979). Filters were blocked by incuba- 
tion with 3% (wt/vol) skimmed milk in PBS overnight and probed with 1 
mg/ml mAb C8A2 for I h at room temperature. After washing with PBS+ 
(wt/vol) 0.05 % Tween 20 filters were incubated with goat anti-mouse IgG 
+IgM coupled to either horse radish peroxidase or alkaline phosphatase. 
Detection of bound antibody was performed after intensive washing with 
either the ECL  detection system (Amersham Buchler GmbH,  Braun- 
schweig, Germany)  or nitro blue  tetrazolium chloride and 5-bromo-4- 
chloro-3-indolyl phosphate as snbstrates for the alkaline phosphatase. 
The isoelectric point of the immunoprecipitated NDP52 was analyzed 
by  two-dimensional  near  equilibrium  pH  gradient  electrophoresis 
(NEPHGE) (O'Farrell et al., 1977) and isoelectric focussing (IEF), using 
Servalyt  Precotes  with  a  pH  range  of  3-10  (Serva  Feinbiochemica 
GmbH, Heidelberg, Germany) according to the instructions of the man- 
ufacturer. 
Isolation and Preliminary Analysis of eDNA Clones 
A  directional, size fractionated eDNA library of human osteosarcoma 
MG63 cells was constructed in h-ZAP using the ZAP-cDNA Gigapack II 
Gold cloning Kit (Stratagene GmbH, Heidelberg, Germany). Approxi- 
mately 106 phages were used for immunoscreening with mAb C8A2 ac- 
cording to the instructions of the picoBlue Immunoscreening Kit (Strat- 
agene GmbH, Heidelberg, Germany). Two phages, clearly reacting with 
mAb C8A2, were isolated and plaque purified. After transformation of 
the positive h-ZAP phages into Bluescript plasmids by in vivo excision re- 
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inserts (done pFK52). 
Cloning of the 5' End of  the NDP52 cDNA by 
Polymerase Chain Reaction 
Amplification of the 5' coding region of NDP52 was performed using the 
5'RACE system (Life Technology GmbH, Eggenstein, Germany). MG63 
total RNA was obtained by lysis of the cells in 4 M guanidinium thiocya- 
nate, 10 mM Tris-HCk pH 7.5, after CsC1 gradient centrifugation (Chirg- 
win et al., 1979). A 20-mer primer (GSPI: GATGAAATGCTGGGTGA- 
AGG) was used to prime reverse transcription of MG63 total RNA using 
SuperScript Reverse Transcriptase (Life Technology GmbH). The gener- 
ated first strand eDNA was tailed at its 3' end with terminal deoxynucle- 
otidyl-transferase in the presence of dCTP. PCR was performed with Taq 
polymerase in a  50  Ixl reaction volume, using a  nested primer (GSP2: 
TATAATGACATGTGACGTCC)  containing an AatlI restriction site, 
plus the anchor primer (Life technology), complementary to the synthetic 
Oligo-dC eDNA tail. The 5' end of the anchor primer contains the XbaI, 
SpeI, and ClaI restnction sites. The RACE product was extracted with 
phenol-chloroform, ethanol precipitated and resuspended in 10 mM Tris- 
HCI, 0.1 mM EDTA, pH 7.6. The amplified DNA was subsequently di- 
gested with the restriction enzymes AatlI and SpeI, and cloned into the 
corresponding restriction sites of the Bluescript plasmid containing the li- 
brary insert of clone pFK52 to generate the construct pFK52c. 
Sequence Analysis 
The pFK52c insert was cloned into the pUC 18 vector in both orienta- 
tions. A  set of deletion clones was generated with the double-stranded 
Nested deletion kit (Pharmacia Biotech Europe GmbH, Freiburg, Ger- 
many).  The  different  clones  were  sequenced by  the  dideoxy method 
(Sanger  et  al,  1977)  using  the  DIG  Taq  Sequencing  Kit  (Boehringer 
Mannheim GmbH, Mannheim, Germany). Overlapping sequences were 
combined to generate the complete sequence of both strands. The part 
containing the RACE product, corresponding to the 5'end was sequenced 
from four different clones to exclude PCR errors. 
Sequence similarity searches of the EMBL-GENBANK and SwissProt 
databases were performed with the FASTA (Pearson, 1990) and BLITZ 
(Smith and Waterman, 1981) programs. Prediction of the secondary struc- 
ture was performed using the algorithm of Kyte  and Doolittle (1982), 
Chou and Fasman (1978),  and the coil algorithm of Lupus et al. (1991), 
implemented in the GENEPRO  (Riverside Scientific Enterprises, Bain- 
bridge Island, WA) and the PC GENE (Intelligenetics, Geel, Belgium) 
software packages. 
In Vitro Transcription  and Translation 
The construct pFK52c was used in a coupled transcription and translation 
assay using the TnT coupled Reticulocyte Lysate system (Promega Corp., 
Madison, WI). The transcript was generated with T7 RNA polymerase 
from  the  circular  plasmid template  and  translated  in  the presence of 
[35S]methionine  in a combined reaction. The translation product was ana- 
lyzed by SDS-PAGE and subsequent fluorography using Amplify (Amer- 
sham Buchler GmbH, Braunschweig, Germany). 
Recombinant Expression  of NDP52 
A  fragment of pFK52c (bp 53-1334) comprising the complete coding re- 
gion for NDP52 was generated by digestion with NcoI, which site contains 
the predicted start codon and BglII, that cuts in the 3' untranslated region 
of the NDP52 cDNA. This fragment was cloned into the corresponding 
restriction sites of the Escherichia coil expression vector pQE60 (Stfiber et 
al.,  1990)  to generate the construct pQEK52.  This construct was intro- 
duced into the E. coil strain M15prep4. NDP52 expression was induced by 
the addition of 2 mM IPTG to the exponentially growing bacteria culture. 
After 3 h cells were pelleted and lysed in SDS sample buffer. Total cell ly- 
sate was analyzed in an immunoblot assay with mAb C8A2. 
Northern Blot Analysis 
The transcription of NDP52 in human tissues was analyzed by hybridizing 
a commercially provided Multiple Tissue Northern Blot (Clontech Labo- 
ratories,  Inc., Palo  Alto,  CA)  with  a  32p-labeled  PstI-fragment of the 
NDP52 cDNA (bp 1-1024). Each lane contains approximately 2 g,g of pu- 
rifled poly(A)  ÷ RNA from one of eight different human tissues standard- 
ized to contain the same amount of [3-actin mRNA. After stringent wash- 
ing with 0.2×  SSC/0.1%  SDS for 1 h  at 65°C, the blot was exposed to 
autoradiography for 1.5 h. 
The  transcription of NDP52  was  further  analyzed  in  the  cell lines 
MG63,  Saos-2, SK-ES-1, HeLa,  COS-7 and human primary skin fibro- 
blasts. Total  RNA was prepared as described above.  15  txg total RNA 
from each cell line were seperated by agarose gel electrophoresis under 
denaturating conditions and blotted onto a nylon filter according to Sam- 
brook et al. (1989). Hybridization was performed as described above. 
HSV-1 and Adenovirus 5 Infection 
Wild-type HSV-1 strain 17 syn  ÷ was used in this study. The mutant strain 
FXE was derived from this strain and contains a deletion in the RING fin- 
ger region of the immediate early transcription factor ICP0, which renders 
it ineffective for transactivation (Everett, 1989; Maul and Everett, 1994). 
All viruses were propagated and titrated in BHK C13 cells grown in mod- 
ified Eagle's medium supplemented with 10% newborn calf serum. HEp-2 
cells were infected with 10 plaque-forming units (pfu). Wild-type HSV-1- 
and HSV-1 FXE-infected cells were fixed after 5 h p.i. Parallel tests with 
mAb against ICP4 indicated that wild-type HSV-1 infected 95% and the 
FXE mutant 85% of the cells. Human fibroblasts (MRC-5) were infected 
with 20 pfu adenovirus 5  (Ad5) in medium without serum for 1 h  after 
which serum was added to a final concentration of 10%. Cells were fixed 
at various times after infection and tested by immunofluorescence label- 
ing with various antibodies. 
Results 
Isolation  of  a mAb Recognizing  a NDIO Antigen 
mAbs that recognize components of ND10 were raised in 
mice immunized with crude nuclei prepared from human 
osteosarcoma cells (MG63). Hybridomas were generated 
as described (Fazeka de St. Groth and Scheidegger, 1980) 
and screened by indirect immunofluorescence analysis for 
nuclear staining on MG63 cells. One mAb, C8A2, showed 
a typical dot-like nuclear staining. The number and size of 
these dots varied in MG63 cells, but ~10 dots per nucleus 
were  observed.  A  similar  staining  pattern  was  also  ob- 
served in the WI38 human fibroblasts and HOS TE85 hu- 
man osteosarcoma cells whereas  neither HeLa cells nor 
primary human skin fibroblasts showed any dot-like stain- 
ing with mAb C8A2 (data not shown). The characteristic 
immunofluorescence staining pattern with the mAb C8A2 
was very similar to that of ND10, indicating that the C8A2 
antigen  could be  part  of this  structure.  Cell  extractions 
with NP-40,  followed by DNaseI  digestion  and  washing 
with 2.0 M NaCl (described in Ascoli and Maul, 1991) did 
not effect the immunofluorescence staining pattern, indi- 
Figure 1.  Analysis of NDP52 
in  SDS-PAGE.  Lanes  1-3 
show immunoblot detections 
of NDP52  with  mAb  C8A2 
in  crude  nuclei  fraction  of 
MG63  cells  (lane  1),  immu- 
noprecipitation  with  mAb 
C8A2 from MG63 cells (lane 
2) and in total E.  coli cell ly- 
sates expressing recombinant 
NDP52  (lane  3).  Lane  4 
shows  a  fluorography  from 
an  SDS-PAGE  of  the  [35S] 
labeled  in  vitro  translation 
(i.v.T.T.)  product  of  the 
NDP52 cDNA (pFK52c). 
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precipitated  NDP52 was separated  by NEPHGE in the first di- 
mension and by SDS-PAGE in the second dimension (a). Sepa- 
rated proteins were transferred to nitrocellulose and detected by 
mAb C8A2. Heavy and light chain of mAb C8A2 are indicated 
by  H  and  L.  For  one-dimensional  IEF,  immunoprecipitated 
NDP52 was separated  by isoelectric focussing and  transferred 
onto nitrocellulose sheets. NDP52 was detected by a rabbit anti- 
serum raised against a recombinant COOH-terminal fragment of 
NDP52 (b). The pls of marker proteins are indicated below the 
blot strip. NDP52 has an pI of 5.5. 
cating a  stable  association of the C8A2 antigen with the 
nuclear matrix (data not shown). Immunoblot analyses of 
the C8A2 antigen using crude nuclear fractions specifically 
identified a protein with an apparent molecular mass of 55 
kD as detected using the ECL system (Fig. 1, lane 1), and a 
weaker signal at HI 10 kD. Immunoprecipitation of the an- 
tigen with mAb C8A2 from whole cell lysates and subse- 
quent immunoblotting also revealed a 55-kD protein (Fig. 
1, lane 2). NEPHGE analysis with an immunoprecipitate 
of C8A2 (Fig.  2 a) showed that the antigen recognized by 
C8A2 was an acidic protein, with a pI of 5 to 6 with no de- 
tectable  charge  isomers.  One-dimensional IEF with  the 
immunoprecipitate of mAb C8A2 allowed a more precise 
determination of the pI at 5.5 (Fig. 2 b). Thus the antigen 
recognized by C8A2 is clearly distinct from the previously 
described  NDP55,  which  has  a  pI of 7.4-7.7  with  three 
charge isomers (Ascoli and Maul, 1991). 
Because mAb C8A2 recognized the  denaturated  anti- 
gen in immunoblot analysis, we used this mAb to screen a 
directional MG63 cDNA library constructed in h-ZAP. 
Isolation of the cDNA Encoding the C8A2 Antigen 
Approximately 6 × 10  5 recombinant phages of this library 
were screened for expression. Two positive phages were 
plaque-purified and subsequently transformed into Blue- 
script plasmids by in vivo excision. Restriction analysis re- 
vealed that both phages contained identical cDNA inserts 
of ~2.3 kb. One cDNA insert was truncated by ExoIII de- 
letion  cloning from both ends.  The subclones generated 
were sequenced by cycle sequencing using Digoxygenin- 
ACTCTGCCCTGTTGCTGTCGCGCCGCTGCTGGTTGCTGTCCCTGGACCCCTACC  54 
,<. 
ATGGAGGAGACCATCAAAGATCCCCCCACATCAGCTGTCTTGCTGGATCACTGTCATTTC  114 
M  E  E  T  I  K  0  P  P  T  S  A  V  L  L  0  H  C  H  F  20 
TCTCAGGTCATCTTTAACAGTGTGGAGAAGTTCTACATCCCTGGAGGGGACGTCACATGT  174 
S  Q  V  I  F  N  S  V  E  K  F  Y  !  P  G  G  D  V  T  C  40 
CATTATACCTTCACCCAGCATTTCATCCCTCGTCGAAAGGATTGGATTGGCATCTTTAGA  234 
H  Y  T  F  T  Q  H  F  I  P  R  R  K  D  M  I  G  ]  F  R  60 
GTGGGGTGGAAGACAACCCGTGAGTATTACACCTTCATGTGGGTTACTTTGCCCATTGAC  294 
V  G  N  K  T  T  R  E  Y  Y  T  F  14  N  V  T  L  P  I  D  80 
CTAAACAACAAAT  CAGCTAAACAGCAGGAAGT  CCAAT  T  CAAAGCT  TACTACCTGCCCAAG  354 
L  N  N  K  S  A  K  Q  Q  E  V  Q  F  K  A  Y  Y  L  P  K  100 
C~T~T~GTATTACCAGTTCTGCTATGTG~T~AG~TGGTGTGGTCCGGG~GC~GT  414 
D  D  E  Y  Y  Q  F  C  Y  V  0  E  D  G  V  V  R  G  A  S  120 
ATTCCTT  TCCAAT  TCCGTCCAGAAAATGAGGAAGACATCCTGGTTGTTACCACTCAGGGA  474 
I  P  F  Q  F  R  P  E  N  E  E  0  !  L  V  V  T  T  Q  G  140 
GAGGT  GGAAGAGAT  T  GAGCAGCACAACAAGGAGCT  T  T  GCAAAGAAAACCAGGAGCT  GAAG  534 
E  V  E  E  l  E  Q  H  N  K  E  l  C  g  E  N  Q  E  L  K  160 
GACAGCT  GTAT  CAGC  CT  CCAGAAGCAGAACT  CAGACATGCAGGCTGAGCT  CCAAAAGAAG  594 
0  S  C  I  S  L  Q  K  Q  N  S  0  M  Q  A  E  L  Q  K  K  180 
CAGGAGGAGCTAGAAACCCTACAGAGCAT  CAATAAGAAGT  T  GGAACT  GAAAGTGAAAGAA  654 
Q  E  E  L  E  T  L  Q  S  ]  N  I(  K  L  E  L  K  V  I(  E  200 
CAGAAGGACTAT  T  GGGAGACAGAGCT  GC  T  T  CAACT  GAAAGAACAAAACCAGAAGAT  GTCC  714 
Q  K  D  Y  N  E  T  E  L  L  Q  L  K  E  Q  N  Q  K  M  S  220 
TCAGAAAATGAGAAGATGGGAATCAGAGTGGATCAGCTTCAGGCCCAGCTGTCAACTCAA  774 
S  E  N  E  K  M  G  I  R  V  D  0  L  Q  A  Q  L  S  T  Q  240 
GAGAAAGAAATGGAGAAGCT  TGTTCAGGGAGATCAAGATAAGACAGAGCAGTTAGAGCAG  834 
E  K  E  M  E  K  L  V  Q  G  D  q  D  K  T  E  Q  L  E  Q  260 
CT  GAAAAAGGAAAAT  GACCACC  T  CT  T  T  CT  CAGT  T  TAACTGAACAGAGGAAGGACCAGAAG  894 
L  K  K  E  I¢  D  H  L  F  L  S  L  T  E  Q  R  K  D  Q  K  280 
AAGCT  C  GAGCAGACAGTGGAGCAAAT  GAAGCAGAAT  GAAACTACT  GCAAT  GAAGAAACAA  954 
K  L  E  Q  T  V  E  Q  M  K  Q  N  E  T  T  A  M  K  K  Q  300 
CAGG~TT~TG~TGAAAACTTTGACCTGTCAAAAA~CTGAGT~G~CGAAATTATA  1014 
Q  E  L  M  0  E  i  F  D  L  S  K  R  L  S  E  N  E  !  I  320 
TGT~TGCTCTGCA~CAGAAAGA~TTGG~G~GAAAATGATCTTTTG~GG  1074 
C  N  A  L..Q..R..9..K,.E..R..L..E..9..E..N..D..L..L..K..R. "  340 
~CAGCAGATTGCTCAGTTACATGGGTCTGGATTTT~TTCTTTGCCGTATC~GTA  1134 
E  N  S  R  l  l  S  Y  M  G  L  D  F  N  S  L  P  Y  0  V  360 
CCTACTTCAGATG~GGAGGCGC~GACAAAATCCAGGACTTGCCTATGGAAACCCATAT  1194 
P  T  S  D  E  G  G  A  R  Q  N  P  G  L  A  Y  G  N  P  Y  380 
TCTGGTATCC~GAAAGTTCTTCCCCCAGCCCGCTCTCCATC~GAAATGCCCTATCTGC  1254 
S  G  [  Q  E  S  S  S  P  S  P  L  S  I  K  K  C  P  ]  C  400 
AAAGCAGATGATATTTGTGATCACACCTTGGAGC~CAGCA~TGCAGCCCCTTTGTTTC  1314 
K  A  D  D  l  C  D  H  T  L  E  Q  Q  Q  M  0  P  L  C  F  420 
~TTGTCC~TTTGTGAC~GATCTTCCCAGCTACAGAG~GCAGATCTTTG~CCAC  13~ 
N  C  P  [  C  D  K  [  F  P  A  T  E  K  Q  [  F  E  D  H  440 
*  W 
GTGTTCTGCCACTCTCTC  1392 
VFCHSL  446 
TGAGTATCCC~CCTCTTGGATGTATA~GATTTTATAGAATAGAACCTATAGCTTCT  1452 
ACCAT~GTTATAT~GTC~GATCCTGCCTMCCTGAAATTATTAGG~TTTACTCAGC  1512 
CCTGCTGCCGCT~CAGTG~GTTATGT~CT~TCTGAAGGT~CTGTTMGGGCTTCT  15~ 
GCTGCCATCCTTGTGGGTTGCTACCTTTMGTCG~TMCTCTAGCTGTAT~TCCTCTC  1~2 
ACCTGTCATTCTTCT~GGGTCTCAGTACMGGGCCCTGG~TG~GCCAACCTGGGTAT  1692 
TCACAACAGGCCTGACTT~TACT~GT~TTAGTTTTCC~GTTGTCC~CTGCCATTC  1~2 
AAAGTCAGCCCTTGAGTGTATTTGTTCTCAGTCCT~CCCTGGGGCCA~TTGGTCCG  1812 
AGGTT~GAATTCCTTCCTCCTCATCCTTGGTGTTGCTTTCTCCAAATGATTGTTTTA~  1872 
CTAGCCAAAAATGCCGTGGCAAAGAGCT~GAAATCCAATTTG~TACCAAAGGTTTCTC  1932 
ATGTT~TTTCTCAGCCCCCAAAGAAGCATCTTACTCCTGAACCTTA~CAGGAAGTATT  1~2 
GTTTCAGTCACAGAAAGCTTTTCTGGGTACCTCTGGTTAGCACTTTCTACTCTCTGATAT  2052 
TTCCTATGTACATAGCTTTTATTGTTGTAAATCCTTTCTT~TGGTTAAATAG~TTGTT  2112 
AGCAACTATGGGTTTGCAGTTTTCTGAGTAGGT~GTTTTGAMATGGGTAAAT~G~T  21~ 
~T~CAACTTGTT~TCTCTTT~TACTAAAAMAAATTACTCTTCTATTT~GG~  2232 
CTTAGGT~TTTAAAATAAACCTTCAATTTATGG1%"1'T'L~'GTTTTGAAGCT~TGGGAAA  2~2 
ATTGT~TCAJUtAG~GGGAAGGGCA~CCCCGCCAATGATTTCTCTT~CCTGTC  2352 
TT~GATTAAAT~GTGTCCTGGCAGTTAAAAAAAAA  23~ 
Figure 3. cDNA sequence and deduced amino acid sequence of 
NDP52. The part of the sequence isolated by the 5'RACE system 
is indicated by an arrow above the sequence. The predicted leu- 
cine zipper is marked by a dotted line. Conserved cysteine resi- 
dues of the LIM-like domain are indicated by asterisks below the 
sequence. Potential polyadenylation sites are underlined. These 
sequence data are available from EMBL/Genbank/DDBJ  under 
accession number U22897. 
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generate the complete cDNA sequence from both strands. 
The resulting cDNA sequence showed a continuous open 
reading frame (ORF)  starting from the 5'  end. The first 
predicted methionine in this sequence was not likely to be 
the  translation  initiation site in vivo since the predicted 
size of the encoded protein was significantly smaller (44 vs. 
55 kD) than that indicated by immunoblotting. Therefore, 
the 5'RACE system was applied to generate a full-length 
cDNA as described in Materials and Methods. Two prim- 
ers, GSP1 and -2, were chosen lying in the analyzed 5' re- 
gion of the cDNA, with the nested GSP2 primer contain- 
ing a natural, unique AatlI restriction site. In agarose gel 
electrophoresis the 5'RACE-PCR product appeared as a 
single DNA band of ~220 bp. After digestion with AatlI 
and SpeI (latter restriction site introduced by the anchor 
primer) the PCR product was ligated into the identically 
treated  Bluescript  plasmid  carrying  the  C8A2  antigen 
cDNA  library insert.  To exclude PCR  errors within the 
amplified product, 4 eDNA clones were analyzed by dide- 
oxy sequencing. The sequence from the 3' end of the PCR 
product, comprising 110 bp, was identical with the already 
known  5'  end  of the  previously isolated  C8A2  antigen 
cDNA  (Fig.  3,  arrow  above  the  sequence),  confirming 
the specific amplification of the target cDNA. The 5' end 
of the  PCR  product  contained  an  additional  90-bp  se- 
quence, which was continuously in-frame with the ORF. 
The relatively small size of the PCR product, as well as its 
reproducibility, makes  it  unlikely  that  a  truncation  of 
the full-length product occurred due to incomplete first- 
stand synthesis. Therefore, the combined sequence of the 
5'RACE PCR product and the cDNA library insert was 
considered to  be  the  full-length  eDNA  of NDP52.  The 
combined eDNA construct in pSK Bluescript, designated 
pFK52C, was subsequently used for in vitro transcription 
and  translation  of the encoded protein. Analyses  of the 
[35S]methionine-labeled translation product by SDS-PAGE 
and subsequent fluorography (Fig. 1, lane 4) showed that 
the translation product was identical in size to that of the 
protein precipitated from MG63 cells by mAb C8A2, sug- 
gesting  that  the  isolated  cDNA  encodes  the  full-length 
protein. 
Recombinant Expression of the C8A2 Antigen in E. coli 
To confirm that the isolated cDNA encodes the protein 
recognized by mAb C8A2, the complete predicted ORF of 
the cDNA was cloned into the E.  coli expression vector 
pQE60  (Stiiber  et  al.,  1990),  generating  the  construct 
pQEK52C. At the 5' end of the cDNA, a natural NcoI site 
containing the presumptive start ATG was used for clon- 
ing. Total cell lysates of induced E.  coli cultures carrying 
the pQEK52C expression plasmid were subsequently ana- 
lyzed by immunoblot analysis. The expressed protein was 
Figure 4. Secondary structure 
predictions  of  NDP52.  The 
different  values  for second- 
ary structure properties are 
indicated  on the y axis plot- 
ted against the amino acid se- 
quence  on  the  x  axis. The 
probability for coiled coil re- 
gions is shown in a. A hydro- 
pathy plot is shown in b. 
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showed the same apparent M r as the protein precipitated 
from MG63 cells by mAb C8A2. These data dearly dem- 
onstrate that mAb C8A2 recognizes the protein encoded 
by the isolated cDNA. In addition a rabbit antiserum was 
raised against a purified recombinant protein encoded by 
the isolated cDNA, consisting of the last 164 COOH-ter- 
minal  amino  acids,  which  reacted  identically  as  mAb 
C8A2 in immunofluorescence and Western blot analyses 
(data not shown). 
Sequence Analysis of the NDP52 cDNA 
The cDNA is 2399 bp in length (Fig. 3), and contains an 
ORF from bp 55 to 1392 that encodes a protein with a pre- 
dicted molecular mass of 52 kD. The slightly higher appar- 
ent mass of the native and recombinant protein in SDS- 
PAGE (Fig. 1) might be explained by stretches of acidic 
residues within the primary sequence, as described for sev- 
eral other proteins, e.g., Spl00 (Szostecki et al., 1990) and 
asparty113-hydroxylase (Korioth et al., 1994). Based on the 
predicted molecular mass and the localization, we named 
the encoded protein, nuclear dot protein 52 (NDP52). The 
presumptive start codon lies within the 5'  region gener- 
ated by the RACE system. Although the ORF continues 
to the 5'end of the cDNA, this ATG is likely to be the ini- 
tiation codon since: (a) the recombinant protein expressed 
product in E. coli, using this ATG as the start codon and 
the  protein  immunoprecipitated  from  MG63  cells  mi- 
grated to identical positions after SDS-PAGE (Fig. 1) and 
(b) the sequence (ACCATGG) surrounding the presump- 
tive start ATG perfectly matches to the optimal sequence 
for eukaryotic initiation of translation (Kozak, 1986). Be- 
sides  the  polyadenylation signal  25  bp  upsteam  of the 
poly-A tail, two more are found at bp 2108 and 2247 (Fig. 
3).  Homology searches in the  current EMBL and  Gen- 
Bank databases using the Fast A  algorithm showed that 
two expressed sequence tags  (accession numbers T23881 
and T07433) describe parts of our cDNA. There is no fur- 
ther strong homology with other sequences in the data- 
bases. However a slight homology of 51% over 700 bp (bp 
500-1200)  was  observed with  the  cDNA  for involucrin 
(AC:  M25314),  a  marker  of keratinocyte differentiation 
(Rice and Green, 1979; Eckert and Green, 1986). Homol- 
ogy of 57% over 250 bp (bp 480-730) was also observed 
with the cDNA of the myosin heavy chain within the re- 
gion encoding the coiled coil tail of myosin. 
NDP52 Is Predicted to Have a Central Coiled 
Coil Domain 
Hydropathy analysis of the predicted amino acid sequence 
of NDP52  shows  a  central  hydrophilic region  of ~200 
amino acids  (Fig. 4  b) with a  high potential to form an 
a-helical structure. This region (amino acids 134-350) has 
a high probability of forming a coiled coil structure as pre- 
dicted by the coil algorithm of Lupas et al.  (1991) (Fig. 4 
a). The probability distribution predicts a sharply defined 
region for this coiled coil structure within NDP52. The ab- 
sence of proline residues further supports this model. The 
amino acid sequence of this region shows a 20-30%  ho- 
mology with the coiled coil regions of different myosin and 
kinesin heavy chains. Another feature of this central re- 
gion is a leucine zipper, ranging from amino acid 324-345, 
within the predicted coiled coil region. This motif, which is 
found in several DNA binding proteins, is thought to pro- 
mote dimerization by forcing a  coiled-coil like structure 
that contains the hydrophobic leucine residues internally 
(Busch and Sasone-Corsi, 1990).  The distribution pattern 
of the  leucine  residues  at  position  1  of the  heptamers, 
forming the coiled coil domain, extends with interruptions 
throughout the complete coiled coil region. Together, our 
data support the model of NDP52 homodimerization by 
an extended central coiled coil domain. 
The small clusters of hydrophobic amino acids found in 
the NH2- and COOH-terminal regions flanking the central 
coiled coil domain (Fig. 4 b) have a higher probability of 
forming 13-sheets and -turns, suggesting a nonhelical, glob- 
ular structure for the NDP52 termini. Potential phosphor- 
ylation sites are found for cAMP- and cGMP-dependent 
protein kinases, PKC, casein kinase II and tyrosine kinase, 
although the biological significance of these sites is still un- 
clear. NDP52, which was characterized as a nuclear pro- 
tein, contains no bipartite or single cluster nuclear local- 
ization signal  within the predicted amino  acid  sequence 
(Dingwall and Laskey, 1991). 
Homology searches with the NH2- and COOH-terminal 
regions of NDP52 in the SWISS PROT database using the 
BLITZ algorithm  revealed  no  significant  homology for 
the NH2 terminus. However, the last 50 amino acids of the 
COOH terminus, which contain 7 cysteine residues, show 
homology to oocyte and gastrula zinc finger proteins, and 
especially to proteins containing a LIM domain (Sadler et 
al., 1992). This domain, which was originally identified in a 
subset of transcription factors, is characterized by one his- 
tidine  and  seven  cysteine  residues  conserved  within  a 
stretch of ~60 amino acids. Analysis of 20 LIM domain se- 
quences has defined the consensus sequence:  CX2CX16-23- 
HX2CX2C2CX16.21CX2.3(C,H,D  )  (Sadler  et  al.,  1992). 
Alignment of the NDP52 COOH terminus with LIM do- 
mains of homologous proteins (Fig. 5) shows that six of the 
seven cysteine residues  of the  NDP52  COOH  terminus 
(asterisks above the sequence) perfectly match with those 
of the LIM domain. In addition to the conserved cysteine 
and histidine residues, the NDP52 COOH terminus shows 
*  *  *  *  *  *  Figure  5.  Alignment  of the 
NDP52  395 ~IPI~-~DDIC~HTL-~QM~L~PI~ID~IF-P~T~KQIFE~H~F~  446  NDP52  COOH  terminus 
CRP  7 t_~K~V~JVYFAEEVQC~GSSFHKS~:~"~-~MV~K~L-DS~TVAVHG~EIY~:~C  60  with  LIM domains.  The resi- 
SF3  9 Q~C~V~'fVYLV~KLVAN~RVYHKA~F~/C~H~qSTL-KLSNFNSFDG~Y~HH  62  dues  of  the  LIM domain  con- 
Zyxin 409 E~SV~KQTITDRMLKAT-GNSYH~_[~T~/M~JHTPLEG~]SFIVDQANQPH~,rDD  463 
1  2  a  4  S  6  7  a  sensus  sequence  are  indi- 
cated  by numbers below the 
sequences. Conserved residues of the NDP52 COOH terminus are indicated by asterisks above the sequence. LIM domains from the 
following proteins are shown: cysteine-rich protein (CRP) (Sadler et al., 1994), Pollen specific protein SF3 (SF3) (Baltz et al., 1992), 
and Zyxin (Sadler et al., 1992). All residues matching with NDP52 are shown in boxes. 
The Journal of Cell Biology, Volume 130, 1995  6 Figure 6. Schematic drawing of the NDP52 structure.  NDP52 has 
a central region with a high probability of forming a coiled coil 
(CC) structure.  At the COOH terminus of this region a leucine 
zipper motif (LZ) is found. The COOH terminus of NDP52 con- 
tains a LIM like domain (LIM-L) with six conserved cysteine res- 
idues of the LIM domain consensus sequence. 
other amino acid matches that are conserved in some LIM 
proteins, including lysine residues flanking the CX2C site 
and a phenyalanine within the second CX2C site. To date 
the biological significance of these residues is unknown. 
In summary, analyses  of the  predicted  amino acid  se- 
quence  of NDP52 gives evidence for three  structural  re- 
gions of this protein (Fig. 6). A  central coiled coil domain 
with  an  integrated  leucine  zipper  probably  causes  ho- 
modimerization of NDP52. The flanking terminal regions 
appear to be globular, with a  LIM-like domain at the ut- 
most COOH terminus. 
NDP52 Is Transcribed in Several Human Tissues and 
Cell Lines 
The  transcription  of NDP52  in  human  tissues  was  ana- 
lyzed by Northern blotting with a  radiolabeled PstI-frag- 
ment  of  the  NDP52  eDNA  (bp  1-1024).  In  all  human 
tissues analyzed, transcription of NDP52 was detected, al- 
though at variable levels (Fig. 7). Brain showed the lowest 
transcription  level  (only  visible  after  longer  exposure), 
whereas skeletal muscle showed the highest level. The size 
of the major transcript  (2.5  kb) fits reasonably well with 
the size of the NDP52 eDNA lacking a poly(A)  + tail (2.4 
kb). The relative broad signal size of this major transcript 
can be explained by two additional polyadenylation sites 
found in the last 200 bp of the 3' untranslated region (Fig. 
3) that might also be used for termination of transcription. 
Furthermore, transcripts larger than 2.5 kb were detected 
in all tissues analyzed. Because our immunoblot data pro- 
vided no evidence for a larger isoform of NDP52 (Fig. 1), 
these larger transcripts are likely to be due to polyadenyla- 
tion signals downstream of those contained in the isolated 
Figure 7. Northern blot anal- 
ysis of NDP52  transcription 
in  eight  human  tissues.  A 
Northern  blot,  containing 
2.5  p~g  poly(A)  ÷  RNA  per 
lane of the respective tissue, 
separated by electrophoresis 
under  denaturating  condi- 
tions  was  hybridized  with  a 
32p-labeled PstI fragment of 
the  NDP52  eDNA.  After 
stringent  washing  the  blot 
was exposed to autoradiogra- 
phy. NDP52 is transcribed in 
all  human  tissues  analyzed, 
showing  multiple  transcript 
lengths. The major transcript 
has a length of 2.5 kb. 
cDNA. 
Further analysis of NDP52 transcription in different cell 
lines by Northern blotting revealed transcription in the hu- 
man  cell  lines  MG63,  SK-ES-1  and  HeLa as  well  as  in 
COS-7 cells (Fig. 8), but not in primary human skin fibro- 
blasts even after longer exposure. The surprising absence 
of any NDP52 transcript, larger than the major 2.5-kb spe- 
cies in  all cell lines presumably reflects  a  difference be- 
tween  transformed  cell  lines  and  primary tissue  cells  in 
transcription termination or processing. 
NDP52 Is a Component of the Nuclear Domain NDIO 
Previously, we showed that PML, Spl00 and NDP55 colo- 
calize to precisely circumscribed nuclear domains (Dyck et 
al., 1994;  Maul and Everett, 1994).  Since NDP52 also ap- 
pears at highest concentrations in nuclear domains similar 
to ND10 and in similar numbers, we tested for colocaliza- 
tion with these proteins. As shown in Fig. 9 a, PML and 
NDP52 colocalize precisely at these domains, except that 
NDP52 is also diffusely present throughout the nucleus at 
a  low level and, in some cells, in domains reminiscent of 
splicing factors (Spector 1993). A  human serum (no. 1785) 
containing  autoantibodies  against  antigens  that  colocalize 
with the splicing factor SC35 was used in double labeling 
with  the  mouse  mAb  C8A2  (Fig  9  b);  although  other 
ND10-associated proteins were clearly not present in re- 
gions,  containing  splicing components,  these  regions  ap- 
peared yellow, indicating colocalization of NDP52 in some 
cells. Thus, unlike all other ND10-associated proteins that 
are not specifically enriched in regions containing splicing 
components, NDP52 is present in more than one nuclear 
domain. 
HSV-I and Adenovirus Cause Different Redistributions 
of NDP52 
HSV-1 removes ND10 from the nucleus, and the immedi- 
ate early gene product type-1 (ICP0) is responsible for this 
redistribution  of ND10-associated  proteins  (Maul  et  al., 
1993).  Analysis to determine the effect of HSV-1 infection 
on NDP52 distribution indicated the apparent absence of 
both PML and NDP52 labeling of ND10 at 5 h after infec- 
tion, although NDP52 remained faintly in areas shown to 
be  domains,  containing  splicing  components  (Fig.  9  c). 
Since not all cells are infected, the area choosen for micro- 
scopic documentation  contained  a  noninfected  cell,  pro- 
viding a convenient control for successful double labeling. 
Figure 8. Northern blot anal- 
ysis of NDP52  transcription 
in different cell lines (A).  A 
Northern blot containing  15 
~g of total RNA per lane of 
the respective cell lines  was 
analyzed  as described  in the 
legend  to  Fig.  7.  Transcrip- 
tion of NDP52  could  be de- 
tected  in  all  cell  lines  ana- 
lyzed, except primary human 
skin  fibroblasts.  The  ethid- 
ium  bromide  stained  28  S 
RNA is shown  as a  loading 
control in B. 
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tains a deletion at the RING finger region essential for re- 
moval  of  ND10  (Maul  and  Everett,  1994;  Everett  and 
Maul,  1994),  ND10  labeling  with  ND10-associated  pro- 
teins remained during early stages of infection, but NDP52 
was not recognizable in the immunofluorescence assay of 
ND10 (Fig. 9 d). The images obtained for NDP52 were the 
same  as  with  wild-type  virus.  In  HSV-l-infected  cells, 
NDP52 reactivity was similar to that  of the  other ND10 
antigens, except that its removal from ND10 does not ap- 
pear to be dependent on ICP0. 
Unlike HSV-1, Ad 5, another DNA virus that replicates 
in  the  nucleus,  segregates ND10-associated proteins into 
tracks 2-3 Ixm in length during the early stages of infection 
(5-9  h  p.i.)  (G.  Maul, personal communication).  Double 
labeling of NDP52 with PML indicated that both proteins 
segregate to these tracks (Fig. 9 e). However, NDP52 was 
removed from these tracks later during infection and accu- 
mulated in the outer rim adjacent to the viral replication 
domains (Fig. 9 f). Viral replication domains were charac- 
terized  by  labeling  with  a  mAb  against  single-stranded 
DNA binding protein (Pombo et al., 1994; data not shown). 
IFN Treatment Induces NDP52 
Type I and II IFN have been shown to increase the number 
and size of nuclear dots containing the ND10 protein Spl00 
(Guldner et al., 1992).  Analogous treatment of MG63 cells 
with 1,000 U/ml of either IFN-[3 or -~ for 18 h resulted in a 
similar increase in number and size of NDP52-specific dots 
(Fig. 10, a  and b). Furthermore, some cells also showed a 
clear cytoplasmic localization  of NDP52  after  IFN treat- 
ment (Fig. 10, c and d). To investigate the effects of IFN on 
NDP52 transcription, a Northern blot containing identical 
amounts of total RNA from IFN-~-stimulated and unstimu- 
lated  MG63  cells was hybridized  as  described  above.  As 
shown in Fig. 11, IFN-~/treatment led to an enhanced tran- 
scription of NDP52, suggesting that the IFN--/-induced in- 
crease in NDP52 immunofluorescence staining reflects en- 
hanced expression of the corresponding protein. 
INF Treatment Reorganizes NDP52 into NDIO 
in COS Cells 
To analyze the conservation of the NDP52 epitope recog- 
nized by the mAb C8A2, we used this antibody for immu- 
noprecipitation of NDP52 from COS-7 cells, which were 
previously  shown  to  transcribe  the  corresponding  gene 
(Fig.  8).  mAb  C8A2  immunoprecipitated  NDP52  from 
COS-7 cells in amounts comparable to those from MG63 
cells (not shown). However, in immunofluorescence anal- 
yses COS-7 cells did not show the typical nuclear dot stain- 
ing, but instead a diffuse staining of the complete nucleus 
(Fig.  10  e).  In  light  of the  relatively close  evolutionary 
Figure 9. NDP52 colocalized with PML and is redistributed upon virus infection. All micrographs  were obtained as single optical sec- 
tions by laser confocal microscopy. Those double labeled were scanned simultaneously  for both labels using pseudocolors  so as to re- 
flect the fluorescent dye, i.e., green for FITC and red for Texas red. (a) HEp-2 cells double labeled for PML and NDP52 resulting in yel- 
low due to perfect overlapping stain. (b) MRC-5 fibroblasts labeled with human serum 1785 recognizing splicing factors (red) and C8A2 
(green). (c) HEp-2 cells 2 h after HSV-1 infection double labeled with anti PML antibodies  (red) and C8A2 (green). ND10 are absent 
except in one uninfected  cell. (d) HEp-2 cells 5 h after infection with the HSV-1 mutant FXE double labeled with anti PML antibodies 
(red) and C8A2 (green). (e) MRC-5 cells infected with Ad5 for 8 h and double labeled with anti PML antibodies  (red) and mAb C8A2 
(green) resulting  in an overlapping  image of fibrous tracks.  (f) MRC-5 cells infected with Ad5 for 16 h and labeled with mAb C8A2 
showing the outer rim of Ad5 replication domains. Bar, 10 Izm. 
The Journal of Cell Biology,  Volume 130, 1995  8 Figure 10. Interferon treatment of MG63 and COS-7 cells. (a) Immunofluorescence analysis of MG63 cells shows a typical dot like stain- 
ing in the nucleus. (b) Treatment with IFN-[3 and -~/leads to an increase in number and size of NDP52-specific dots. INF-~/treatment of 
MG63 cells partially leads to a redistribution of NDP52 to the cytoplasm (d) as shown by comparison with phase contrast of the same 
cell (c). (e) COS-7 cells show a diffuse fluorescence staining of the nucleus with mAb C8A2. (tO Treatment with IFN-[3 however, leads in 
N10% of the cells to the appearance of NDP52-specific nuclear dots. Bar, 10 ixm. 
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of the generally species-specific human IFN-B on NDP52 
distribution in COS-7 cells. Immunofluorescence analysis 
revealed a  general increase in  nuclear staining  and  also 
NDP52-specific dots of varying intensity in ~10%  of the 
cells (Fig.  10 f). Identical results were gained with HeLa 
cells, which showed without stimulation a diffuse nuclear 
distribution of NDP52, and NDP52-specific dots after treat- 
ment with IFN-13 (data not shown).  Thus NDP52 is not 
only distributed in ND10, but in some cell lines also in a 
diffuse nuclear localization from which it can be reorga- 
nized to ND10 by treatment with IFN-13. 
Discussion 
The nuclear domain ND10, also described as POD or Kr 
bodies, has been characterized using a  variety of human 
autoimmune sera and monoconal antibodies (Ascoli and 
Maul, 1991; Stuurman et al., 1992; Xie et al., 1993; Dyck et 
al.,  1994; Koken et al.,  1994; Weis et al.,  1994).  The fact 
that  several different antibodies recognize this  structure 
suggests that ND10 is a multiprotein complex. Thus far the 
cDNA sequences for two ND10 proteins, Spl00 and PML, 
have been characterized (Szostecki et al., 1990; Kazikuka 
et al.,  1991,  de The et al.,  1991).  A  direct interaction of 
PML and Spl00 could not be demonstrated (Koken et al., 
1994), suggesting, that other structures or proteins are re- 
quired for their association in colocalization experiments. 
Here we describe the isolation and characterization of 
a cDNA  encoding  the  novel  ND10-associated  protein, 
NDP52.  The  mAb,  C8A2,  which  specifically recognizes 
NDP52,  was  generated  in  mice  immunized  with  crude 
nuclei  fractions from the  human  osteosarcoma cell line 
MG63.  Immunofluorescence analysis  of MG63  cells  re- 
vealed a typical nuclear dot staining with mAb C8A2 that 
was very similar to the ND10 staining described by Ascoli 
and Maul  (1991).  Subsequent colocalization experiments 
with ND10-specific antibodies confirmed that mAb C8A2 
recognizes  a  component  of  this  structure.  Immunoblot 
analyses of crude nuclei fractions used for immunization 
and  for immunoprecipitation  revealed  that  mAb  C8A2 
specifically recognizes a protein with an apparent molecu- 
lar mass of 55 kD. NEPGHE analyses and IEF of the im- 
munoprecipitated antigen of C8A2 characterized it as an 
acidic protein with  a  pI  of 5.5  without charge isoforms. 
The  combined  use  of  expression  screening  and  the  5' 
RACE system enabled the isolation of a cDNA encoding 
Figure 11. IFN-~/treatment  of MG63 cells 
leads to an increase in NDP52 transcrip- 
tion. Northern blot was performed as de- 
scribed in legend to Fig. 7. An autoradiog- 
raphy  of  the  hybridization  of  identical 
amounts of total RNA from unstimulated 
(-) and stimulated (+) MG63 cells with a 
32p-labeled NDP52  cDNA  fragment  is 
shown  in  A.  The  ethidium  bromide 
stained 28 S RNA is shown in B. 
the antigen recognized by mAb C8A2. Based on its local- 
ization in immunofluorescence analyses and the predicted 
molecular  mass  we  designated  this  antigen  nuclear  dot 
protein (NDP) 52. The isolated cDNA was characterized 
by recombinant expression in E. coli and specific detection 
of the recombinant protein by mAb C8A2 in immunoblot 
analysis of total cell extracts. A  rabbit  antiserum  raised 
against the recombinant COOH terminus of the encoded 
protein  yielded  identical  results  in  immunofluorescence 
and  immunoblot  analyses  to  those  obtained  with  mAb 
C8A2 (data not shown). 
The protein encoded by the NDP52 cDNA consists of 
446 amino acids with a predicted mass of 52 kD. Second- 
ary structure analysis of the amino acid sequence predicts 
an extended coiled coiled domain (Lupas et al., 1991) in 
the central region of the NDP52 protein consisting of hep- 
tamers  with  hydrophobic residues  at  positions  1  and  4. 
This region also shows homology to parts of the myosin 
and  kinesin  heavy  chains,  which  are  known  to  have  a 
coiled coil structure in vivo. Thus, the observed homology 
is probably due to the structural requirements for a coiled 
coil domain. A leucine zipper motif is found at the COOH- 
terminal end of the predicted coiled coil region. Leucine 
zippers are known to promote homo- and heterodimeriza- 
tion in several transcription factors, probably by forming a 
coiled coil-like structure (Struhl, 1989). However, the clus- 
ters of basic amino acids that act as DNA binding domains 
in transcription factors and that are usually located adja- 
cent to the leucine zipper are not found in the NDP52 se- 
quence. Consistent with these predictions is the presence 
of an additional protein band of ~110 kD detected with 
mAb  C8A2  in  immunoblot  analysis  of nuclei  fractions. 
Based on the considerations above, this band likely repre- 
sents unseparated homodimers. Further investigations will 
determine whether such homo- or heterodimerization oc- 
curs in vivo. Coiled coil domains described for several pro- 
teins form homodimers that usually aggregate to filaments 
(Cohen  and  Parry,  1990).  The  colocalization of several 
proteins within ND10 probably also requires aggregation 
of these proteins by still unknown interactions. Interest- 
ingly, coiled coil regions are also predicted for the two ge- 
netically  characterized  ND10-associated  proteins,  PML 
and  Spl00  (Koken  et  al.,  1994),  suggesting  that  these 
domains may lead to an aggregation of these and as yet 
uncharacterized  proteins  to  form  the  complex  ND10 
structure. 
In contrast to the hydrophilic central region, the flank- 
ing NH2- and COOH-terminal regions of NDP52 show a 
relatively high potential to form 13-sheets and -turns. These 
regions  might  therefore have  a  more globular  structure 
compared to the extended central coiled coil region. The 
overall predicted structure of NDP52 i.e., a large central 
coiled coil domain flanked by nonhelical terminal domains 
appears to be quite similar to that of intermediate filament 
proteins. 
The predicted amino acid sequence of NDP52 contains 
no clear nuclear location signal. Therefore, the nuclear lo- 
calization can be  explained by an  unregulated diffusion 
through  the  nuclear  pore  complex  (Peters,  1986)  as  it 
would be possible for a protein of 52 kD or by the exist- 
ence of a nuclear location signal within the tertiary struc- 
ture of NDP52. Nuclear localization of NDP52 could also 
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which is targeted to the nucleus. 
Sequence  comparision  revealed  a  weak  homology of 
NDP52 with involucrin, a marker of terminal keratinocyte 
differentiation (Rice and Green, 1979; Eckert and Green, 
1986),  which comprises the  central coiled coil region of 
NDP52 and extends over 700 bp (51% identity) including 
an encoded stretch of 200 amino acid (22% identity). This 
homology at both the gene and protein levels raises the 
possibility of a common evolutionary origin of these genes. 
Remarkably,  the  function  of  involucrin  is  crosslinking 
plasma membrane proteins via covalent ~-(~/-glutamyl)lysine 
bonds  (Simon  and  Green,  1988)  mediated  by  a  trans- 
glutaminase,  and several of the involved glutamine resi- 
dues in involucrin are conserved in NDP52. Thus NDP52 
and involucrin might share a similar function. 
Homology searches with the nonhelical NH  2 -and COOH- 
terminal  domains  alone  revealed  that  the  cysteine  rich 
COOH terminus of NDP52 showed homology to several 
members of the LIM domain protein family (Crawford et 
al.,  1992).  The LIM domain was shown to bind two Zn  2+ 
ions  that  are  tetrahedrally  coordinated at  four  cysteine 
and  three  cysteine plus  one histidine  sites  (Kosa  et  al., 
1994). Alignment of NDP52 with LIM domains of several 
proteins shows a perfect match between six cysteine resi- 
dues of NDP52 and those of the LIM domain consensus 
sequence. Besides the conserved residues of the LIM do- 
main, lysine residues flanking the CX2C sites as well as one 
phenylalanine  residue  within  this  site  are  conserved  in 
NDP52 and some of the LIM domain proteins. Based on 
these homologies, the COOH terminus of NDP52 can be 
considered a LIM-like domain. In determining the biologi- 
cal significance of this LIM-like domain, it will be impor- 
tant to investigate whether the natural or the E.  coli de- 
rived recombinant NDP52  actually contains  bound  zinc. 
Recent studies have confirmed that LIM domains mediate 
protein-protein  interactions  (Schmeichel  and  Beckerle, 
1994; Wadman et al., 1994). A LIM-like domain in NDP52 
that mediates similar protein-protein interactions would 
make this protein a likely candidate for accumulating itself 
and other proteins within the nuclear dots of ND10. Alter- 
natively, NDP52 could be responsible for their specific lo- 
calization  within  the  nucleus  by  mediating  interactions 
with the nuclear matrix. 
Transcription of NDP52 was detected in vivo in all hu- 
man  tissues  analyzed.  The  variations  observed in  tran- 
scription levels suggest that the function of the encoded 
protein is not tissue specific. NDP52 transcripts were de- 
tectable after  1.5-h  autoradiography exposure of the hy- 
bridized Northern blot, indicating high in vivo transcrip- 
tion levels of this gene. Of all tissues and cells analyzed, 
human primary skin fibroblasts were NDP52-negative in 
Northern- and  immunofluorescence analyses.  Therefore, 
despite its expression in most human tissues and cell lines, 
NDP52 may be not essential for normal cell growth and di- 
vision. 
Virus replication often leads to a destruction of the nu- 
clear  organization  as  a  consequence  of  the  expanding 
space the viral replication domains occupy. However, ND10 
is modified much earlier during virus infection (Maul et 
al., 1993; Maul and Everett, 1994), indicating, that the as- 
sociated proteins may have some functions in early events 
of the viral life cycle. NDP52 is eliminated from ND10 by 
HSV-1. In early stages of infection ICP0, one of the imme- 
diate  early  transactivating  HSV-1  proteins,  transiently 
colocalizes with  PML  and  Spl00.  This  colocalization is 
also  found with NDP52,  except that it is removed from 
ND10 even if a HSV-1 mutant with a nonfunctional ICP0 
is used for infection. Therefore, NDP52 is removed inde- 
pendently of other ND10-associated proteins and distrib- 
uted throughout the nucleus with an increase of staining 
found in regions containing splicing factors. Although the 
significance of this observation is not clear it demonstrates 
that the colocalization of ND10-associated proteins can be 
abrogated by virus infection, in the course of which they 
may exert their different specific functions. 
Ad5, a DNA virus from another family modifies ND10 
in a different way. During infection with Ad5, PML is seg- 
regated to fibrous tracks together with Spl00 and NDP55 
(not shown). NDP52 also transiently moves to these tracks 
but like Spl00 it is later recruited to the viral replication 
domains. The specific distribution of NDP52 in the outer 
rim of the developing Ad5 replication domains suggests 
that it localizes with the sites of viral transcription, that 
have recently been demonstrated by the incorporation of 
bromo-UTP (Pombo et al.,  1994).  NDP52 remains at the 
outer rim of the expanding replication domain of Ad5 and 
is finally recognized at the nuclear envelope in a distribu- 
tion similar to that observed for snRNPs.  Together with 
the findings that NDP52 distributes to some degree to ar- 
eas enriched in splicing factors we may speculate that it is 
likely to be involved in viral transcription or posttranscrip- 
tional processing. In contrast to HSV-1, that has no late 
genes that require splicing, Ad5 is dependent on the host 
cell splicing apparatus for the processing and maturation 
of viral transcripts  (Pombo et  al.,  1994).  It has  recently 
been shown,  that splicing occurs at sites of transcription 
and  not  in  nuclear  speckles,  containing  splicing  factors 
(Zhang  et  al.,  1994).  Although  these  domains therefore 
rather appear as storage or accumulation sites for excess 
splicing factors, the  colocalization of NDP52  with  these 
factors still  supports  the  possibility that  it  might  be  in- 
volved in splicing processes. 
Treatment of MG63 cells with IFN led to an increase in 
number  and  size  of NDP52-specific dots,  and  to  an  in- 
crease of the NDP52 transcript levels. These results sug- 
gest an IFN-induced enhanced expression of NDP52, com- 
parable  to  that  described  for  the  ND10  protein  Spl00 
(Guldner et al.,  1992).  In addition to their colocalization, 
the very similar IFN regulation of NDP52 and Spl00 ar- 
gues for a  shared function that might depend on a  direct 
interaction  in  a  multiprotein  complex.  However,  IFN 
treatment had an additional effect on NDP52, inducing a 
cytoplasmic distribution  of the protein in  some  cells.  A 
similar cytoplasmic localization of ND10 proteins was re- 
cently described for PML (Everett and Maul, 1994). Relo- 
cation of PML to the cytoplasm is thought to be caused by 
interactions with a nuclear targeting deficient ICP0. Shut- 
tling  between  the  nucleus  and  cytoplasm has  been  de- 
scribed for several proteins (reviewed in Laskey and Ding- 
wall,  1993).  In  contrast  to  the  highly regulated  nuclear 
import of proteins, export from the nucleus was recently 
demonstrated to be independent of specific export signals, 
and is instead a  consequence of lost retention (Schmidt- 
Korioth et al.  Characterizatton  of  NDP52, a Novel Protein of  Nuclear Domain 10  11 Zachmann et al.,  1993).  This,  in turn,  suggests  that pro- 
teins are released from the nucleus by processes, that re- 
duce  the  affinity  to  nuclear  structures.  Such  processes 
leading  to  the  cytoplasmic  relocation  of ND10  proteins 
might  comprise  interactions  with  IFN-induced  or  viral 
proteins  as  well  as  IFN-induced  modification  of  ND10 
proteins. Interestingly, the two different in vitro inducers 
of relocation of ND10 proteins to the cytoplasm, i.e., IFN 
treatment and virus infection, reflect an identical in vivo 
situation; organisms respond to virus infection with pro- 
duction of IFNs, which induce a  variety of proteins with 
antiviral  actions  (Samuel,  1991).  Thus,  IFN-induced  en- 
hanced expression of ND10  proteins as well as their ob- 
served relocation to the cytoplasm might be part of a com- 
mon antiviral function. 
Immunofluorescence analysis of COS-7 cells, that tran- 
scribe and express NDP52 revealed no dot like staining us- 
ing mAb C8A2 and instead, a diffuse nuclear distribution 
of  NDP52.  IFN-~  treatment  induces  the  relocation  of 
NDP52 into ND10. This effect was also observed in HeLa 
cells (not shown). In contrast to the diffuse nuclear distri- 
bution  of NDP52  in  COS-7  and HeLa  cells  before  IFN 
treatment (not shown), mAb138 detected the ND10 struc- 
ture as nuclear dots in these  cells.  However, in all other 
cell  lines  investigated,  the  antigens  recognized  by  both 
mAbs were already colocalized in ND10 without any stim- 
ulation. Therefore, redistribution of NDP52 to ND10 can 
either be explained, by the induction of other proteins in 
COS-7  and  HeLa  cells  interacting  with  NDP52  to form 
this  structure  or  by  an  IFN-I~  induced  modification  of 
NDP52  increasing  its  affinity  to  ND10.  Studies  of IFN- 
induced  gene  expression  and  NDP52  modification  in 
NDP52-positive cells without dot structures will help us to 
test this hypothesis. 
The NDP52 protein characterized here is a novel com- 
ponent of ND10.  In addition to its colocalization with the 
ND10 proteins Spl00 and PML, NDP52 also shares struc- 
tural  and regulatory features with them. The  results  for 
NDP52 support a model of ND10 as a multiprotein com- 
plex,  whose  components  might  function  synergistically. 
Previously reported data on ND10 proteins and those for 
NDP52  suggest the involvement of ND10 proteins in the 
viral life cycle. The growing number of genetically charac- 
terized ND10 proteins will allow a more detailed analysis 
of their presumed function as well as their involvement in 
APL. 
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